India and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...

Indian markets await clarity on Strait of Hormuz shipping. Ashi Anand of IME Capital suggests a defensive market approach. Oil prices near ...

BSE Sensex and Nifty 50 extended gains for a second session, led by banking, metal and pharma stocks despite IT weakness. Analysts flagged ...

Domestic equity benchmarks ended marginally higher after four sessions of losses, supported by gains in metal, energy and consumer stocks. ...

Indian stock markets ended in the green, with Sensex and Nifty snapping a four-session losing streak. This occurred despite the rupee hitti...

Twelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...

US Ambassador to India, Sergio Gor, attended a White House dinner with President Trump, discussing US-India ties and global stability. Gor ...

Odisha aims to become a leading pharmaceutical and medical device investment hub, as highlighted at the Odisha Pharma Summit 2025.

The Indian government plans to establish 50 new greenfield pharma and medical device plants under the PLI scheme within two years. This fol...

NITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...

Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...

According to statement from Assam government the company has already invested Rs 700 crore in this manufacturing facility in the state and ...

"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."

This will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...

The Centre is coming out with a revised strategy for 'Jan Aushadhi' scheme, which seeks to provide quality medicines at affordable price, t...

Choosing not to make a direct comment on the impasse over the takeover of Singapore-based Parkway Holdings, Fortis group promoter Malvinder...

With the Indian pharmaceutical industry making rapid strides in the last few years, many observers are betting on the country becoming an a...